The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Steinhart Richard I since 2016.
This trader's CIK number is 1293789.
At the time of last reporting, Steinhart Richard I was the Chief Financial Officer of Bioxcel Therapeutics, Inc.. (stock ticker symbol BTAI).
Also see all insider trading activities at Bioxcel Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | ATNM | 2,500 | $5,024 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | BTAI | 0 | $0 | 0 | $0 | 758 | $0 |
| 2024 | BTAI | 0 | $0 | 9,549 | $7,683 | 6,021 | $0 |
| 2023 | BTAI | 0 | $0 | 7,084 | $176,503 | 8,647 | $0 |
| 2021 | BTAI | 0 | $0 | 3,750 | $180,562 | 3,750 | $20,812 |
| 2018 | BTAI | 1,500 | $7,600 | 0 | $0 | 0 | $0 |
1. Actinium Pharmaceuticals, Inc. (ATNM)
2. Bioxcel Therapeutics, Inc. (BTAI)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-04-14 | ATNM | Buy | 2,500 | 2.01 | 5,024 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-22 | BTAI | Option Ex | 625 | .00 | 0 |
| 2025-06-15 | BTAI | Option Ex | 35 | .00 | 0 |
| 2025-06-14 | BTAI | Option Ex | 33 | .00 | 0 |
| 2025-03-14 | BTAI | Option Ex | 31 | .00 | 0 |
| 2025-03-15 | BTAI | Option Ex | 34 | .00 | 0 |
| 2024-12-16 | BTAI | Sale | 577 | .36 | 207 |
| 2024-12-15 | BTAI | Option Ex | 562 | .00 | 0 |
| 2024-12-14 | BTAI | Option Ex | 521 | .00 | 0 |
| 2024-10-03 | BTAI | Sale | 7,175 | .55 | 3,946 |
| 2024-09-15 | BTAI | Option Ex | 563 | .00 | 0 |
| 2024-09-16 | BTAI | Sale | 356 | .69 | 245 |
| 2024-09-14 | BTAI | Option Ex | 521 | .00 | 0 |
| 2024-06-14 | BTAI | Option Ex | 521 | .00 | 0 |
| 2024-06-15 | BTAI | Option Ex | 562 | .00 | 0 |
| 2024-06-17 | BTAI | Sale | 372 | 1.26 | 469 |
| 2024-03-14 | BTAI | Option Ex | 521 | .00 | 0 |
| 2024-03-15 | BTAI | Option Ex | 2,250 | .00 | 0 |
| 2024-04-04 | BTAI | Sale | 1,069 | 2.63 | 2,816 |
| 2023-12-14 | BTAI | Option Ex | 521 | .00 | 0 |
| 2023-09-14 | BTAI | Option Ex | 521 | .00 | 0 |
| 2023-06-14 | BTAI | Option Ex | 521 | .00 | 0 |
| 2023-05-14 | BTAI | Option Ex | 5,000 | .00 | 0 |
| 2023-05-15 | BTAI | Sale | 5,000 | 27.17 | 135,865 |
| 2023-03-15 | BTAI | Sale | 2,084 | 19.50 | 40,638 |
| 2023-03-14 | BTAI | Option Ex | 2,084 | .00 | 0 |
| 2021-02-01 | BTAI | Option Ex | 3,750 | 5.55 | 20,812 |
| 2021-02-01 | BTAI | Sale | 3,750 | 48.15 | 180,562 |
| 2018-12-03 | BTAI | Buy | 500 | 5.20 | 2,600 |
| 2018-11-30 | BTAI | Buy | 500 | 5.00 | 2,500 |
| 2018-11-29 | BTAI | Buy | 500 | 5.00 | 2,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Steinhart Richard I (Chief Financial Officer of Bioxcel Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.